Transplantation for type 1 diabetes: Whole organ pancreas and islet cells

Current Diabetes Reports

Volumn 6, Issue 6, 2006, Pages 473-478

  Pavlakis, Martha ^a   Khwaja, Khalid ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HEPARIN; IMMUNOSUPPRESSIVE AGENT; INSULIN; RAPAMYCIN; TACROLIMUS;

BLOOD GLUCOSE MONITORING; CELL SELECTION; COST EFFECTIVENESS ANALYSIS; DIABETIC NEPHROPATHY; ENDOLEAK; EVIDENCE BASED MEDICINE; GRAFT FAILURE; GRAFT OCCLUSION; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FAILURE; KIDNEY PANCREAS TRANSPLANTATION; KIDNEY TRANSPLANTATION; LIVER HEMATOMA; LOW DRUG DOSE; OUTCOME ASSESSMENT; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PATIENT SAFETY; REVIEW; RISK BENEFIT ANALYSIS; SURGICAL DRAINAGE; SURGICAL MORTALITY; SURGICAL TECHNIQUE; THROMBOSIS; TREATMENT INDICATION; UNSPECIFIED SIDE EFFECT; URINARY TRACT DISEASE;

DIABETES MELLITUS, TYPE 1; GRAFT SURVIVAL; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; PANCREAS TRANSPLANTATION; TREATMENT FAILURE; TREATMENT OUTCOME; URINARY BLADDER;

EID: 33845451866     PISSN: 15344827     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11892-006-0082-z     Document Type: Review

References (33)

1. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group [no authors listed]. N Engl J Med 1993, 329:977-986.
2. International Pancreas Transplant Registry: 2003 Annual Report. Available at http://www.iptr.umn.edu/IPTR/annual_reports/2003_annual/ total.html. Accessed June 2006.
3. Collaborative Islet Transplant Registry: 2005 Annual Report. Available at http://web.emmes.com/study/isl/index.html. Accessed June 2006.
4. Gruessner AC, Sutherland DER: Analysis of United States (US) and non-US pancreas transplants reported to the United Network for Organ Sharing (UNOS) and the International Pancreas Transplant registry (IPTR) as of October 2001. In Clinical Transplants 2001. Edited by Cecka JM, Terasaki PI. Los Angeles: UCLA Tissue Typing Laboratory; 2002:41-72.
5. Fernandez LA, Turgeon NA, Odorico JS, et al.: Superior long-term results of simultaneous pancreas-kidney transplantation from pediatric donors. Am J Transplant 2004, 4:2093-2101.
6. Gross CR, Zehrer CL: Health-related quality of life outcomes of pancreas transplant recipients. Clin Transplant 1992, 6:165-171.
7. Shapiro AMJ, Lakey JRT, Ryan EA, et al.: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid free immunosuppressive regimen. N Engl J Med 2000, 343:230-238.
8. Scientific Registry of Transplant Recipients (SRTR): 2005 Annual Report. Available at http://www.ustransplant.org. Accessed June 2006.
9. Mazur M, Rea D, Griffin MD, et al.: Decline in native renal function early after bladder-drained pancreas transplantation. Transplantation 2004, 77:844-849.
10. Ojo AO, Meier-Kriesche HU, Hanson JA, et al.: The impact of simultaneous pancreas-kidney transplantation on long-term patient survival. Transplantation 2001, 71:82-90.
11. Venstrom JM, McBride MA, Rother KI, et al.: Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 2003, 290:2817-2823.
12. Gruessner RWG, Sutherland DE, Gruessner AC: Mortality assessment for pancreas transplants. Am J Transplant 2004, 4:2018-2026.
13. Bhargava R, Senior PA, Ackerman TE, et al.: Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. Diabetes 2004, 53:1311-1317.
14. Andres A, Toso C, Morel P, et al.: Impairment of renal function after islet transplant alone or islet-after-kidney transplantation using a sirolimus/tacrolimus-based immunosuppressive regimen. Transpl Int 2005, 18:1226-1230.
15. Fioretto P, Steffes MW, Sutherland DER, et al.: Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998, 339:69-75.
16. Konigsrainer A, Miller K, Steurer W, et al.: Does pancreas transplantation influence the course of diabetic retinopathy? Diabetologia 1991, 34(suppl 1):S86-S88.
17. Koznarova R, Saudek F, Sosna T, et al.: Beneficial effect of pancreas and kidney transplantation on advanced diabetic retinopathy. Cell Transplant 2000, 9:903-908.
18. Giannarelli R, Copelli A, Sartini MS, et al.: Early improvement of unstable diabetic retinopathy after solitary pancreas transplantation. Diabetes Care 2002, 25:2358-2359.
19. Ramsey RC, Goetz FC, Sutherland DE, et al.: Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. N Engl J Med 1998, 318:208-214.
20. Navarro X, Sutherland DE, Kennedy WR: Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol 1997, 42:727-736.
21. Allen RD, Al-Harbi IS, Morris JG, et al.: Diabetic neuropathy after pancreas transplantation: determinants of recovery. Transplantation 1997, 63:830-838.
22. Jukema J, Wouter MD, Smets YF, et al.: Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to type 1 diabetes. Diabetes Care 2002, 25:906-911.
23. Gaber AO, Wicks MN, Hathaway DK, Burlew BS: Sustained improvement in cardiac geometry and function following kidney-pancreas transplantation. Cell Transplant 2000, 9:913-918.
24. Fiorina P, La Rocca E, Astorri E, et al.: Reversal of left ventricular diastolic dysfunction after kidney-pancreas transplantation in type 1 diabetic uremic patients. Diabetes Care 2000, 23:1804-810.
25. La Rocca E, Fiorina P, Di Carlo V, et al.: Cardiovascular outcomes after kidney-pancreas and kidney-alone transplantation. Kidney Int 2001, 60:1964-1971.
26. Elliot MD, Kapoor A, Parker MA, et al.: Improvement in Hypertension in patients with diabetes mellitus after kidney/pancreas transplantation. Circulation 2001, 104:563-569.
27. Coppelli A, Giannarelli R, Mariotti R, et al.: Pancreas transplant alone determines early improvement of cardiovascular risk factors and cardiac function in type 1 diabetic patients. Transplantation 2003, 76:974-976.
28. Sureshkumar KK, Mubin T, Mikhael N, et al.: Assessment of quality of life after simultaneous pancreas-kidney transplantation. Am J Kidney Dis 2002, 39:1300-1306.
29. Stratta RJ, Weide LG, Sindhi R, et al.: Solitary pancreas transplantation. Experience with 62 consecutive cases. Diabetes Care 1997, 20:362-368.
30. Sutherland DER, Gruessner RW, Dunn DL, et al.: Lessons learned from more than 1000 pancreas transplants at a single institution. Ann Surg 2001, 233:463-501.
31. Ryan EA, Bigam D, Shapiro AMJ: Current indications for pancreas or islet transplant. Diabetes Obes Metab 2006, 8:1-7.
32. American Diabetes Association: Pancreas transplantation for patients with type 1 diabetes. Diabetes Care 2004, 27:S105.
33. Mandal AK, Drew N, Lapidus JA: The effect of center volume on pancreas transplant outcomes. Ann Surg 2004, 136:225-231.